Stablepharma Begins Final Human Trial for First Fridge-Free Vaccine

London, Wednesday, 7 October 2026.
Stablepharma has dosed the first patient in a pivotal 160-person Phase 2b trial for its fridge-free tetanus-diphtheria vaccine, which can withstand temperatures up to 40°C for six months.